NO991733L - FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering - Google Patents

FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering

Info

Publication number
NO991733L
NO991733L NO991733A NO991733A NO991733L NO 991733 L NO991733 L NO 991733L NO 991733 A NO991733 A NO 991733A NO 991733 A NO991733 A NO 991733A NO 991733 L NO991733 L NO 991733L
Authority
NO
Norway
Prior art keywords
preparation
igm
intravenous administration
immunoglobulin
protease
Prior art date
Application number
NO991733A
Other languages
English (en)
Norwegian (no)
Other versions
NO991733D0 (no
Inventor
Markus Rentsch
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of NO991733D0 publication Critical patent/NO991733D0/no
Publication of NO991733L publication Critical patent/NO991733L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO991733A 1996-10-14 1999-04-13 FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering NO991733L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810690A EP0835880A1 (de) 1996-10-14 1996-10-14 Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation
PCT/CH1997/000388 WO1998016558A1 (de) 1996-10-14 1997-10-14 VERFAHREN ZUR HERSTELLUNG EINES IgM-PRÄPARATES FÜR DIE INTRAVENÖSE APPLIKATION

Publications (2)

Publication Number Publication Date
NO991733D0 NO991733D0 (no) 1999-04-13
NO991733L true NO991733L (no) 1999-06-11

Family

ID=8225725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991733A NO991733L (no) 1996-10-14 1999-04-13 FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering

Country Status (19)

Country Link
US (1) US6136312A (cs)
EP (1) EP0835880A1 (cs)
JP (1) JP2001504092A (cs)
KR (1) KR20000048826A (cs)
CN (1) CN1233258A (cs)
AU (1) AU725134B2 (cs)
BR (1) BR9712306A (cs)
CA (1) CA2266848A1 (cs)
CZ (1) CZ125599A3 (cs)
HU (1) HUP0001069A3 (cs)
ID (1) ID21364A (cs)
IL (1) IL129383A0 (cs)
NO (1) NO991733L (cs)
NZ (1) NZ334885A (cs)
PL (1) PL332774A1 (cs)
RU (1) RU2191032C2 (cs)
SI (1) SI9720063A (cs)
SK (1) SK46699A3 (cs)
WO (1) WO1998016558A1 (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8142780B2 (en) * 1998-08-20 2012-03-27 Strox Biopharmaceuticals, Llc Anti-bacterial antibodies
DE602004030451D1 (de) * 2003-07-15 2011-01-20 Chugai Pharmaceutical Co Ltd Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm-produktion
EP1688432B1 (en) * 2003-10-09 2011-08-03 Chugai Seiyaku Kabushiki Kaisha Igm high concentration stabilized solution
EP1686137A4 (en) 2003-10-09 2009-10-28 Chugai Pharmaceutical Co Ltd Method of stabilizing protein solutions
US8852585B2 (en) * 2006-01-30 2014-10-07 Grifols Therapeutics Inc. Method of treatment and prophylaxis of diseases related to amyloid deposition using IgM
FR2899111B1 (fr) * 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament.
EP2291196A4 (en) * 2008-05-12 2012-05-30 Strox Biopharmaceuticals Llc FOR STAPHYLOCOCCUS AUREUS SPECIFIC ANTIBODY PREPARATIONS
CN101721633B (zh) * 2008-10-16 2011-12-21 岳道友 一种促进动物生长的中草药
GB201006753D0 (en) * 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
RU2470664C2 (ru) * 2010-08-23 2012-12-27 Андрей Германович Лютов Способ получения иммуноглобулина для внутривенного введения, обогащенного иммуноглобулином м, и препарат, полученный этим способом
WO2015187779A1 (en) 2014-06-03 2015-12-10 Xbiotech, Inc. Compositions and methods for treating and preventing staphylococcus aureus infections
UY39318A (es) * 2020-07-10 2022-02-25 Grifols Worldwide Operations Ltd Procedimiento para obtener una composicion que comprende inmunoglobulina m derivada de plasma humano

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin
DE2901822A1 (de) * 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
US4371520A (en) * 1981-10-28 1983-02-01 The Green Cross Corporation Process for preparing immunoglobulin suitable for intravenous injection
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
IT1186766B (it) * 1985-11-08 1987-12-16 Sclavo Spa Metodo per la preparazione di immunoglobuline per uso endovenoso
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
DE3927112C1 (cs) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate

Also Published As

Publication number Publication date
RU2191032C2 (ru) 2002-10-20
SI9720063A (sl) 1999-08-31
NO991733D0 (no) 1999-04-13
US6136312A (en) 2000-10-24
ID21364A (id) 1999-05-27
EP0835880A1 (de) 1998-04-15
HUP0001069A2 (hu) 2000-10-28
CA2266848A1 (en) 1998-04-23
WO1998016558A1 (de) 1998-04-23
NZ334885A (en) 2000-09-29
IL129383A0 (en) 2000-02-17
CZ125599A3 (cs) 1999-07-14
KR20000048826A (ko) 2000-07-25
BR9712306A (pt) 1999-08-31
JP2001504092A (ja) 2001-03-27
HUP0001069A3 (en) 2000-12-28
AU4449597A (en) 1998-05-11
SK46699A3 (en) 2000-06-12
CN1233258A (zh) 1999-10-27
PL332774A1 (en) 1999-10-11
AU725134B2 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
NO991733L (no) FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering
ATE155043T1 (de) Behandlung von autoimmun- und entzundungskrankheiten
DE69535243D1 (de) Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
DE69532961D1 (de) Verwendung von porphyrine in der behandlung von multiple sklerose
ATE147258T1 (de) Haarnachbehandlungsmittel
ATA29495A (de) Zusammensetzung und verfahren zur prävention und behandlung von entzündungen mit immunglobulin a
NO941589L (cs)
DE69333626D1 (de) Verwendung von Adamantan Derivaten zur Herstellung eines Medikaments zur GLAUKOMBEHANDLUNG
DE59105609D1 (de) Verwendung von anti-TNF-Antikörpern als Arzneimittel bei der Behandlung von Ischämien und deren Folgen.
EP0648127A4 (en) SURFACE ANTIGENS OF TYPES I AND II ASSOCIATED WITH STAPHYLOCOCCUS EPIDERMIDIS.
DE59008404D1 (de) Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oder IgA-haltige Immunglobulinpräparate.
DK166763C (da) Immunoglobulin-g-holdig fraktion
ATE45961T1 (de) Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung.
EP0733361A3 (en) Method for inactivating enveloped viruses and sperm
ATE148348T1 (de) Behandlung von einer autoimmun-krankheit
NO890046L (no) Disubstituerte pyridiner.
ATE37182T1 (de) Imidazolinone und imidazolidinthione, verfahren zu deren herstellung und verwendung dieser verbindungen als herbizide.
DK0659082T3 (da) Anvendelse af cytochrom P450 inhibitorer til inhibering af metabolismen af nitrogensubstituerede acridiner
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
NO950925D0 (no) Preparat og fremgangsmåte for behandling av hårtap
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
ATE129712T1 (de) Substituierte pyrido-oxazine.
ATE147269T1 (de) Behandlung von männerunfruchtbarkeit
ATE24834T1 (de) Verwendung von beta-(1-adamantyl)-alpha, alphadimethylethylamin zur herstellung eines arzneimittels zur behandlung von otitis externa bei hunden.
PT65644B (de) Verfahren zur herstellung von 1,3-gleichsubstituierten triazin-2,4-dionen sowie deren verwendung als insektizide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application